Communities in Ecuador's Amazon rainforest have sent a heartfelt video message to Chevron CEO John Watson: "We don't want to continue dying of cancer."

This urgent appeal calls on Chevron

Communities in Ecuador's Amazon rainforest have sent a heartfelt video message to Chevron CEO John Watson: "We don't want to continue dying of cancer."

This urgent appeal calls on Chevron to clean up its massive contamination of the Ecuadorian Amazon. The pollution has devastated the environment and continues to cause widespread cancer, birth defects, and other severe health problems.

The message was originally published in January 2010.

Activists Marshall Ganz, Rachel Laforest, and Madeline Janis explain how organized people achieve social change. Ganz, affiliated with the Leading Change

Activists Marshall Ganz, Rachel Laforest, and Madeline Janis explain how organized people achieve social change. Ganz, affiliated with the Leading Change Network, highlights the distinction between movements and special interests, the power of strategy and narrative, and that the powerful don't always win. Visit Marshall Ganz's website for more insights.

His book, Why David Sometimes Wins: leadership, organization and strategy in the California farm worker movement, delves into these themes. An interview, "Why Stories Matter," also references Paul Tillich's Love, Power and Justice, another recommended read. Both books are available on Amazon or at your local bookstore.

In an October 2013 interview with Bill Moyers, author Wendell Berry—hailed as a "prophet of

In an October 2013 interview with Bill Moyers, author Wendell Berry—hailed as a "prophet of responsibility" and "passionate advocate for the Earth"—shared his views on leadership.

Berry believes true leadership emerges from the bottom up. It involves individuals who identify a need and act on it. He asserts that success is not the primary concern; rather, the fundamental question is, "What's the Right Thing to do?"

Published by TEDxBrussels on November 3, 2013, this presentation features Dr. Steven Laureys, MD, PhD.

Dr. Laureys, who leads the Coma Science Group at the